Amy Moore, Ph.D., VP, Global Engagement and Patient Partnerships at LUNGevity Foundation speaks about LUNGevity Foundation Launches New Lung Cancer Patient Gateways.
Link to LUNGevity:
https://www.lungevity.org/
Link to Article:
https://www.lungevity.org/news/media-releases/lungevity-foundation-launches-new-lung-cancer-patient-gateways
The LUNGevity Foundation, the country’s foremost lung cancer nonprofit, has launched a new resource called Lung Cancer Patient Gateways. The KRAS Patient Gateway is the first to go live, and it will make it easier for cancer patients with the KRAS gene mutation to obtain resources and treatment information, as well as connect with other patients and caregivers.
The KRAS Patient Gateway is a user-friendly and easily available information site that provides persons with KRAS markers for lung cancer with the most up-to-date medical information and potentially lifesaving tools. People living with lung cancer will be able to learn about KRAS, find a specialist based on individualized search criteria, join a variety of KRAS communities, explore clinical trial options, and read up-to-the-minute, curated news and trends through the Gateway, which will be available at kras.lungevity.org.
The KRAS Patient Gateway is the first of six platforms that will be available at gateway.lungevity.org over the next six months. The remaining five will focus on different types of lung cancer, such as non-small cell and small cell lung cancer, as well as specific mutations that initiate and support lung cancer growth, such as ALK (anaplastic lymphoma kinase), EGFR (epidermal growth factor receptor), and other rare mutations like ROS1, MET, NTRK, BRAF, RET, and others.